Apimeds Opens For Trading In Slow IPO Week
May 11, 2025 at 14:00 PM EDT
Inflammation drug developer Apimeds Pharmaceuticals made its public debut this week, as it started trading at $4 on Friday and raised about $13.5 million in gross proceeds. Additionally, American Integrity Insurance opened on May 8 at $18.50.
